0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV-92.60%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma13.52Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Arcus Biosciences Stock Discussion
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx(ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics(ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics(BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals(CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals(DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics(FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals(FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...
2022前三季度营收增长1.8倍到0.8亿,营业利润亏损缩小至2.1亿,净利润亏损缩小至2亿,全年利润完全看第四季度的表现,目前很难评估其投资价值。
In reaction to earnings/guidance:
• $GoodRx(GDRX.US)$ +38.5%, $EDGIO(EGIO.US)$ +13.5%, $Lemonade(LMND.US)$ +10.7%, $Desktop Metal(DM.US)$ +8.5%, $ShockWave Medical(SWAV.US)$ +8.2%, $Pubmatic(PUBM.US)$ +8.1%, $Olaplex(OLPX.US)$ +7%, $Vivid Seats(SEAT.US)$ +6.4%, $Noble(NE.US)$ +6.3%, $Aspen Technology(AZPN.US)$ +5.4%, $AAON Inc(AAON.US)$ +5%, $Hudbay Minerals(HBM.US)$ +5%, $Vivint Smart Home(VVNT.US)$ +4.9%, $Vivint Smart Home(VVNT.US)$ +4...
• $Arcus Biosciences(RCUS.US)$ +11.2% (appointed to join S&P SmallCap 600)
• $Sphere 3d(ANY.US)$ +10.13% (mutually agreed to terminate merger agreement with Gryphon Digital Mining)
• $Theravance Biopharma(TBPH.US)$ +3.05% (announced results from Study 0170)
• $Carnival(CUK.US)$ +4.7% (reported that March 28-April 3 was the busiest booking week in company history)
• $Castle Biosciences(CSTL.US)$ +4.4% (agreed to acquire Althe...
No comment yet